AI Buyer Insights:

Citigroup, a VestmarkONE customer evaluated BlackRock Aladdin Wealth

Cantor Fitzgerald, a Kyriba Treasury customer evaluated GTreasury

Westpac NZ, an Infosys Finacle customer evaluated nCino Bank OS

Swedbank, a Temenos T24 customer evaluated Oracle Flexcube

Michelin, an e2open customer evaluated Oracle Transportation Management

Moog, an UKG AutoTime customer evaluated Workday Time and Attendance

Wayfair, a Korber HighJump WMS customer just evaluated Manhattan WMS

Citigroup, a VestmarkONE customer evaluated BlackRock Aladdin Wealth

Cantor Fitzgerald, a Kyriba Treasury customer evaluated GTreasury

Westpac NZ, an Infosys Finacle customer evaluated nCino Bank OS

Swedbank, a Temenos T24 customer evaluated Oracle Flexcube

Michelin, an e2open customer evaluated Oracle Transportation Management

Moog, an UKG AutoTime customer evaluated Workday Time and Attendance

Wayfair, a Korber HighJump WMS customer just evaluated Manhattan WMS

List of ProChain Fusion Customers

Apply Filters For Customers

Logo Customer Industry Empl. Revenue Country Vendor Application Category When SI Insight
Abbott Healthcare 114000 $42.0B United States ProChain ProChain Fusion Project Portfolio Management 2015 n/a
In 2015, Abbott deployed ProChain Fusion for Project Portfolio Management to support R&D and new product introductions in the United States. ProChain lists Abbott as a life sciences client using the ProChain System to support those functions, establishing ProChain Fusion as the application in use. The implementation emphasized multi-project and portfolio synchronization, leveraging ProChain Fusion capabilities such as pipeline visualization, schedule modeling, and portfolio-level reporting. Module usage is inferred to include Fusion Online or Fusion Pipeline for multi-project synchronization and centralized reporting rather than an explicitly named module in the public reference. Operational scope focused on R&D and new product introduction workflows across Abbott United States operations, impacting product development, portfolio management, and project scheduling functions. The ProChain Fusion deployment provided portfolio orchestration and formalized schedule governance to align cross-functional project portfolios. ProChain reports that Abbott experienced improvements in schedule predictability and time-to-market, outcomes directly associated with the ProChain Fusion Project Portfolio Management implementation and its portfolio synchronization and reporting practices. Governance adjustments likely reinforced stage gate alignment and regular portfolio reporting cadence to sustain those improvements.
Medtronic Healthcare 50000 $19.8B United States ProChain ProChain Fusion Project Portfolio Management 2015 n/a
In 2015, Medtronic implemented ProChain Fusion to improve project delivery and program synchronization across product development in the United States. Medtronic appears on ProChain’s client lists in the medical devices and life sciences section, indicating a public ProChain Fusion customer relationship. This deployment aligns with Project Portfolio Management objectives for enterprise multi-project control and program synchronization. The implementation likely leverages ProChain Fusion capabilities such as Fusion Pipeline or Fusion Online for enterprise multi-project management, concentrating on centralized pipeline management, program scheduling, resource capacity planning, and portfolio-level sequencing. ProChain Fusion was configured to support portfolio and program views, milestone orchestration, and stage or gate sequencing consistent with Project Portfolio Management functional workflows. Operational coverage focused on product development and program management teams within Medtronic in the United States, with governance oriented toward portfolio prioritization and cross-program synchronization. Rollout and process adjustments would emphasize centralized intake, cadence-driven program reviews, and coordinated resource allocation to synchronize multiple development streams. The deployment is described as being used to improve project delivery and program synchronization across Medtronic product development.
Roche Life Sciences 112774 $80.3B Switzerland ProChain ProChain Fusion Project Portfolio Management 2015 n/a
In 2015, Roche implemented ProChain Fusion for Project Portfolio Management, adopting the application to accelerate clinical and product development programs with Roche Diagnostics cited among ProChain’s life sciences clients in the Switzerland region. The implementation positioned ProChain Fusion as the central portfolio layer for program oversight and decision support across diagnostic development efforts. Roche likely configured ProChain Fusion using capabilities aligned to ProChain’s Fusion Online and Fusion Pipeline offerings, emphasizing portfolio visibility and resource synchronization. Configuration emphasis was on pipeline management, capacity planning, prioritization workflows, and stage gate sequencing to align program intake with development resourcing and timelines. Operational coverage focused on clinical and product development functions within Roche Diagnostics in Switzerland, with the application supporting cross-functional program teams and centralized portfolio reporting. Integrations were oriented to program governance processes and resource management workflows rather than specific third party systems, enabling synchronized planning between project leads and resource owners. Governance changes accompanied the rollout, with ProChain Fusion used to enforce portfolio governance, stage gate oversight, and standardized prioritization. ProChain reported major gains in predictability and portfolio control as outcomes of the deployment, and Roche used ProChain Fusion for Project Portfolio Management to improve visibility and coordination across its development portfolio.
Showing 1 to 3 of 3 entries

Buyer Intent: Companies Evaluating ProChain Fusion

ARTW Buyer Intent uncovers actionable customer signals, identifying software buyers actively evaluating ProChain Fusion. Gain ongoing access to real-time prospects and uncover hidden opportunities. Companies Actively Evaluating ProChain Fusion for Project Portfolio Management include:

  1. De Beers Group, a United Kingdom based Retail organization with 20000 Employees
  2. Intel, a United States based Manufacturing company with 88400 Employees
  3. BFC Technologies, a Canada based Manufacturing organization with 50 Employees

Discover Software Buyers actively Evaluating Enterprise Applications

Logo Company Industry Employees Revenue Country Evaluated
No data found
FAQ - APPS RUN THE WORLD ProChain Fusion Coverage

ProChain Fusion is a Project Portfolio Management solution from ProChain.

Companies worldwide use ProChain Fusion, from small firms to large enterprises across 21+ industries.

Organizations such as Roche, Abbott and Medtronic are recorded users of ProChain Fusion for Project Portfolio Management.

Companies using ProChain Fusion are most concentrated in Life Sciences and Healthcare, with adoption spanning over 21 industries.

Companies using ProChain Fusion are most concentrated in Switzerland and United States, with adoption tracked across 195 countries worldwide. This global distribution highlights the popularity of ProChain Fusion across Americas, EMEA, and APAC.

Companies using ProChain Fusion range from small businesses with 0-100 employees - 0%, to mid-sized firms with 101-1,000 employees - 0%, large organizations with 1,001-10,000 employees - 0%, and global enterprises with 10,000+ employees - 100%.

Customers of ProChain Fusion include firms across all revenue levels — from $0-100M, to $101M-$1B, $1B-$10B, and $10B+ global corporations.

Contact APPS RUN THE WORLD to access the full verified ProChain Fusion customer database with detailed Firmographics such as industry, geography, revenue, and employee breakdowns as well as key decision makers in charge of Project Portfolio Management.